LuciPona 45 mg Tablet
Prescription Required
Brand Name:
LuciPona
Molecule:
PonatinibStrength:
45 mg
Quantity:
30 Tablets
Form:
Tablet
Packaging Type:
Bottle
Manufacturer/Marketed By:
Lucius PharmaCountry of Origin:
Laos
Enquiry Form
Similar Products:
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
| Ponaxen Ponatinib 45 mg Tablet | Everest Pharma | Ask for Price |
References
LuciPona (Ponatinib), a potent kinase inhibitor specifically formulated to target chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Each tablet of LuciPona contains 45mg of Ponatinib, designed for adult patients who have shown resistance or intolerance to at least two prior kinase inhibitors.
LuciPona is indicated for:
Chronic phase (CP) CML provides a vital treatment option for patients facing challenges with previous therapies.
– Accelerated phase (AP) or blast phase (BP) CML, as well as Ph+ALL, ensuring patients without other kinase inhibitors available receive the care they need.
– T315I-positive CML or Ph+ALL across all phases, offering a targeted approach for those with this specific mutation.
Related Products
Lucirux Ruxolitinib 5 mg Tablet
Molecule: Ruxolitinib
Manufacturer: Lucius Pharma
Ask for Price
Enquiry Form
Related Posts:
No matching posts found.
Reviews
Clear filtersThere are no reviews yet.